157 related articles for article (PubMed ID: 2743271)
21. Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).
Herold M; Schulze A; Niederwieser D; Franke A; Fricke HJ; Richter P; Freund M; Ismer B; Dachselt K; Boewer C; Schirmer V; Weniger J; Pasold R; Winkelmann C; Klinkenstein C; Schulze M; Arzberger H; Bremer K; Hahnfeld S; Schwarzer A; Müller C; Müller C;
J Cancer Res Clin Oncol; 2006 Feb; 132(2):105-12. PubMed ID: 16088404
[TBL] [Abstract][Full Text] [Related]
22. [Results of the pilot treatment of 9 patients with chronic lymphocytic leukemia or CLL lymphoplasmacytoid lymphoma by the CHOP protocol].
Roliński J; Rupniewska ZM; Kowalewski J; Kowal M; Wach M
Acta Haematol Pol; 1990; 21(2):185-91. PubMed ID: 2131718
[TBL] [Abstract][Full Text] [Related]
23. Rate of M-component changes and clinical course of 23 responsive myeloma patients.
Riccardi A; Montecucco C; Merlini G; Cremonini N; Danova M; Ascari E
Haematologica; 1984; 69(3):305-14. PubMed ID: 6432642
[No Abstract] [Full Text] [Related]
24. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.
Bosanquet AG; McCann SR; Crotty GM; Mills MJ; Catovsky D
Acta Haematol; 1995; 93(2-4):73-9. PubMed ID: 7543720
[TBL] [Abstract][Full Text] [Related]
25. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
[TBL] [Abstract][Full Text] [Related]
26. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
27. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.
Montserrat E; Alcalá A; Parody R; Domingo A; García-Conde J; Bueno J; Ferrán C; Sanz MA; Giralt M; Rubio D
Cancer; 1985 Nov; 56(10):2369-75. PubMed ID: 3899346
[TBL] [Abstract][Full Text] [Related]
28. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
[TBL] [Abstract][Full Text] [Related]
29. The management of chronic lymphocytic leukemia at a single centre over a 24-year period: prognostic factors for survival.
Karmiris T; Rohatiner AZ; Love S; Carter M; Ganjoo RK; Amess J; Norton AJ; Lister TA
Hematol Oncol; 1994; 12(1):29-39. PubMed ID: 7515019
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of chronic lymphocytic leukemia in relation to clinico- morphological characteristics of the disease].
Tumakov VA; Abdulkadyrov KM; Rugal' VI; Karpenkov MV; Ved' VV; Brodovskiĭ AF
Klin Med (Mosk); 1991 Jan; 69(1):94-7. PubMed ID: 2023411
[TBL] [Abstract][Full Text] [Related]
31. Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukemia resolved by Rituximab.
Shvidel L; Shtalrid M; Berrebi A
Leuk Lymphoma; 2004 Jul; 45(7):1493-4. PubMed ID: 15359657
[No Abstract] [Full Text] [Related]
32. [Primary malignant lymphoma of the urinary bladder achieving complete response by COMPA intraarterial chemotherapy: a case report].
Ueda T; Yamauchi T; Kageyama S; Tsuzuki M; Kawakami S; Yonese J; Kawai T
Nihon Hinyokika Gakkai Zasshi; 1994 Jun; 85(6):1006-9. PubMed ID: 8065071
[TBL] [Abstract][Full Text] [Related]
33. 2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger.
Robak T; Błoński JZ; Urbańska-Ryś H; Błasińska-Morawiec M; Skotnicki AB
Leukemia; 1999 Apr; 13(4):518-23. PubMed ID: 10214856
[TBL] [Abstract][Full Text] [Related]
34. Alternating intravenous courses of melphalan and peptichemio in high-risk multiple myeloma (preliminary results).
Franchi F; Seminara P; Rossi Fanelli F
Anticancer Res; 1986; 6(2):297-8. PubMed ID: 3707066
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
Tefferi A; Li CY; Reeder CB; Geyer SM; Allmer C; Levitt R; Michalak JC; Addo F; Krook JE; Witzig TE; Schaefer PL; Mailliard JA
Leukemia; 2001 Aug; 15(8):1171-5. PubMed ID: 11480558
[TBL] [Abstract][Full Text] [Related]
36. Hemorrhagic pleural effusion as a complication of chronic lymphocytic leukemia.
Zeidman A; Yarmolovsky A; Djaldetti M; Mittelman M
Haematologia (Budap); 1995; 26(3):173-5. PubMed ID: 7797147
[TBL] [Abstract][Full Text] [Related]
37. Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
Levitt MJ; Gharibo M; Strair R; Schaar D; Rubin A; Bertino JR
J Chemother; 2009 Aug; 21(4):434-8. PubMed ID: 19622463
[TBL] [Abstract][Full Text] [Related]
38. Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia.
Leuk Lymphoma; 1994 May; 13(5-6):449-56. PubMed ID: 8069190
[TBL] [Abstract][Full Text] [Related]
39. [Recent therapy for refractory myeloma].
Togawa A
Rinsho Ketsueki; 1993 Apr; 34(4):450-4. PubMed ID: 8510332
[TBL] [Abstract][Full Text] [Related]
40. [Results of the combined treatment of advanced multiple myeloma by the M-2 protocol: cyclophosphamide, vincristine, melphalan, nitrosourea and prednisone].
Gola A; Niewolna M; Weryńska B
Pol Arch Med Wewn; 1987 May; 77(5):200-5. PubMed ID: 3078182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
